Accurately assess and monitor airway inflammation

While airway inflammation is known to be the major underlying characteristic of asthma, there are few methods of measuring it. Evaluating airway inflammation using induced sputum or airway biopsy is considered the gold standard however it is expensive, invasive, time-consuming, and often not readily available.

The majority of patients with asthma have Type 2/Th2 allergic/eosinophilic driven airway inflammation and higher levels of nitric oxide (NO) in their exhaled breath.4 By measuring the concentration of NO in an exhaled breath (fractional exhaled nitric oxide or FeNO), clinicians can evaluate airway inflammation in patients with asthma.

NIOX VERO® is a non-invasive, simple and safe, and time-saving FeNO device which offers:

By clicking Yes you will be taken to a third-party website or websites to which Circassia's Privacy Policy and other rules do not apply. Circassia is not responsible for the privacy policy of any third-party websites. You are solely responsible for interactions with such third-party website(s).